Cargando…

Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients

Liver transplant recipients are immunocompromised and have low immunogenicity to produce antibodies in anti-COVID-19 vaccination. Whether immunosuppressant adjustment could facilitate anti-COVID-19 antibody production in anti-COVID-19 mRNA vaccination is undetermined. Our patients were informed to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wei-Chen, Hung, Hao-Chien, Lee, Jin-Chiao, Huang, Chung-Guei, Huang, Po-Wei, Gu, Po-Wen, Wang, Yu-Chao, Cheng, Chih-Hsien, Wu, Tsung-Han, Lee, Chen-Fang, Wu, Ting-Jung, Chou, Hong-Shiue, Chan, Kun-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051347/ https://www.ncbi.nlm.nih.gov/pubmed/36992386 http://dx.doi.org/10.3390/v15030678

Ejemplares similares

Determinants of Antibody Response to SARS-CoV-2 Vaccines in Liver Transplant Recipients: The Role of Immunosuppression Reduction
por: Cheng, Chih-Hsien, et al.
Publicado: (2022)

Sedative and Immunosuppressive Effects of Dexmedetomidine in Transplantation
por: Lee, Chen-Fang, et al.
Publicado: (2021)

Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipients
por: Hung, Hao‐Chien, et al.
Publicado: (2020)

Significance of Hepatitis B Recurrence in Liver Transplantation Recipients
por: Chou, Hong-Shiue, et al.
Publicado: (2020)

A review of split liver transplantation with full right/left hemi-liver grafts for 2 adult recipients
por: Chan, Kun-Ming, et al.
Publicado: (2021)

Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant Patients
por: Hsu, Po-Jung, et al.
Publicado: (2021)

Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease
por: Lee, Wei-Chen, et al.
Publicado: (2017)

Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients
por: Thorat, Ashok, et al.
Publicado: (2014)

Encouraging Split Liver Transplantation for Two Adult Recipients to Mitigate the High Incidence of Wait-List Mortality in the Setting of Extreme Shortage of Deceased Donors
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Reconstruction of Separated Intrahepatic Ducts Using the Cystic and Common Hepatic Ducts in Right-Lobe Living-Donor Liver Transplantation: Experiences of Surgical Techniques, Biliary Complications, and Outcomes in a Single Institution
por: Hsu, Po-Jung, et al.
Publicado: (2022)

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
por: Hung, Hao-Chien, et al.
Publicado: (2020)

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma
por: Lee, Wei‐Chen, et al.
Publicado: (2020)

Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein
por: Lee, Jin-Chiao, et al.
Publicado: (2021)

Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation
por: Lee, Wei-Chen, et al.
Publicado: (2021)

Living-Donor Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Score and Predictive Value of NLR on Survival
por: Hung, Hao-Chien, et al.
Publicado: (2022)

Individualized Selection Criteria Based on Tumor Burden in Future Remnant Liver for Staged Hepatectomy of Advanced CRLM: Conventional TSH or ALPPS
por: Chan, Kun-Ming, et al.
Publicado: (2022)

Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation
por: Cheng, Chih-Hsien, et al.
Publicado: (2023)

Elevation of Lipid Metabolites in Deceased Liver Donors Reflects Graft Suffering
por: Lee, Wei-Chen, et al.
Publicado: (2023)

Recurrence Patterns After Hepatectomy With Very Narrow Resection Margins for Hepatocellular Carcinoma
por: Cheng, Chih-Hsien, et al.
Publicado: (2022)

Preferred Treatment with Curative Intent for Left Lateral Segment Early Hepatocellular Carcinoma under the Era of Minimal Invasive Surgery
por: Wu, Tsung-Han, et al.
Publicado: (2022)

Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
por: Lai, Yin, et al.
Publicado: (2022)

Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma
por: Lee, Jin-Chiao, et al.
Publicado: (2019)

Improving outcomes of liver resection for hepatocellular carcinoma associated with portal vein tumor thrombosis over the evolving eras of treatment
por: Wang, Yu-Chao, et al.
Publicado: (2021)

De Novo Endotoxin-Induced Production of Antibodies against the Bile Salt Export Pump Associated with Bacterial Infection following Major Hepatectomy
por: Chan, Kun-Ming, et al.
Publicado: (2018)

Implementation of sorafenib treatment for advanced hepatocellular carcinoma: an illustration of current practice in Taiwan
por: Chan, Kun-Ming, et al.
Publicado: (2019)

“Left at right” liver transplantation with heterotopic implantation of left liver graft in the right subphrenic space: Reappraisal and technical concerns for decision making
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Salvage living donor liver transplantation for posthepatectomy recurrence: a higher incidence of recurrence but promising strategy for long-term survival
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Impact of donor with evidence of bacterial infections on deceased donor liver transplantation: a retrospective observational cohort study in Taiwan
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan
por: Chen, Yi-Chan, et al.
Publicado: (2016)

Calreticulin regulates vascular endothelial growth factor-A mRNA stability in gastric cancer cells
por: Lee, Po-Chu, et al.
Publicado: (2019)

Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment
por: Chan, Kun-Ming, et al.
Publicado: (2023)

Prescription trends of immunosuppressive drugs in post-heart transplant recipients in Taiwan, 2000–2009
por: Chou, Chia-Lin, et al.
Publicado: (2014)

Myeloid-derived suppressor cells in the patients with liver resection for hepatitis B virus-related hepatocellular carcinoma
por: Lee, Wei-Chen, et al.
Publicado: (2019)

Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma
por: Wu, Tsung-Han, et al.
Publicado: (2020)

Crowding-facilitated macromolecular transport in attractive micropost arrays
por: Chien, Fan-Tso, et al.
Publicado: (2017)

DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis
por: He, Tsung-Ying, et al.
Publicado: (2016)

Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan
por: Liu, Hsi-Ling, et al.
Publicado: (2023)

Cancer and mTOR inhibitors in kidney transplantation recipients
por: Kao, Chih-Chin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_th17a8slee88tcke6p837lm66k